Cogent Biosciences, Inc. — Director's Dealing 2022

Jun 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cogent Biosciences, Inc. (COGT)
CIK: 0001622229
Period of Report: 2022-06-07

Reporting Person: Shegog Todd (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-07	Stock Option (Right to Buy)	$4.59	A	30700	Acquired	2032-06-07	Common Stock (30700)	Direct

Footnotes

F1: This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders.